Many individuals worldwide suffer from chronic liver disease (CLD), which poses significant concerns for its tendency to lead to hepatocellular...

MONDAY, Sept. 9, 2024 -- Women with hepatocellular carcinoma (HCC) are less likely to receive a deceased-donor liver transplant (DDLT) and more...

Empagliflozin, an SGLT2 inhibitor, is proven safe and effective for heart attack patients, offering a new treatment option to improve outcomes.

TUESDAY, Sept. 10, 2024 -- For adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve...

THURSDAY, Aug. 29, 2024 -- In patients with abdominal pain and gallstones, a more restrictive approach may avoid unnecessary cholecystectomies, with...

A new editorial was published in Oncotarget‘s Volume 15 on July 24, 2024, entitled, “Beyond pixels: Graph filtration learning unveils new...

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with...

Findings indicate that testosterone therapy in trans men alters immune system responses, suggesting implications for disease susceptibility and...

Researchers at the Medical College of Georgia at Augusta University, USAm are searching for a better way to understand why many men with prostate...

FRIDAY, Sept. 6, 2024 -- A computed tomography (CT)-based radiomics nomogram model can achieve favorable efficacy for predicting low-risk patients...